Agios Stock Down Year: Why It Fell 16% and What Next
Biotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
Explore the wash sale rule as it applies to dividend ETFs and strategies to avoid unnecessary tax complications.
12,423 articlesBiotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
A Reuters briefing this week reignited the debate over Banksy’s anonymity and its effect on art values, prompting a r...
Showings unveils a no-listing-fee brokerage model that relies on assisting agents and AI to speed listings, betting b...
Aging homeowners are turning estate sales into a routine part of listings, prompting a need for a formal checklist re...
Bill Gates is downshifting his Seattle-area estate footprint, listing a neighboring home and pruning parcels around X...
Summit Funding plans large-scale layoffs as CrossCountry Mortgage advances its acquisition. About 163 employees will ...
California lawmakers move to tighten a five-year-old starter-home law, with SB 1116 clearing the Senate 37-0 and head...
Strategy’s market value has slipped below the value of its own Bitcoin holdings, reversing years of a premium for BTC...
Xenon stock sits at $42 as insiders trim significant positions ahead of a pivotal March Phase 3 readout. This guide b...
A notorious short-seller unloaded sofi this week with sweeping accusations, but the stock shrugged off most of the blow.
A notable fund sold a sizable stake in a leading pet-food company, triggering questions about motive, timing, and imp...
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...